[SGPT increase in hemophilia patients during treatment with blood coagulation factor preparations].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D001779:Blood Coagulation Factors / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006467:Hemophilia A / Q000097:blood / Q000628:therapy*; D002836:Hemophilia B / Q000097:blood / Q000628:therapy*; D006509:Hepatitis B / Q000276:immunology / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies
D001779:Blood Coagulation Factors; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D000410:Alanine Transaminase
SGPT-verhogingen bij hemofiliepatiënten tijdens behandeling met stollingsfactorpreparaten.